Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы

HER2/EGFR in Cancer Research

Работ: 17

  1. Morphological Features of Tumor in Different Treatment Options for Patients with Locally Advanced Breast Cancer

    Khodjaeva Dilrukh Ilkhomovna

    СтатьяMonoclonal and Polyclonal Antibodies Research2021Цитирований: 2
    ABI

  2. Pharmacological Evaluation of F45 on the Cardiovascular System Using In Vitro, In Vivo Models and Molecular Dockings

    Ikbolkhon Abdurazakova, Anvar Zaynabiddinov, Izzatullo Abdullaev +6

    СтатьяCardiac Imaging and DiagnosticsTrends in Sciences2025Цитирований: 2
    ABI

  3. Radioiodination and biodistribution of the monoclonal antibody TU-20 and its scFv fragment

    Veronika Kleinová, Hana Chaloupková, Helena Švecová +1

    СтатьяMonoclonal and Polyclonal Antibodies ResearchJournal of Radioanalytical and Nuclear Chemistry2010Цитирований: 0
    ABI

  4. 1141 Clinical Use of HER2 Extracellular Domain as a Marker to Monitor Cancer Status and Predict the Response to Anti-cancer Treatment in Breast Cancer

    Keiichi Kontani, S. Hashimoto, Chisa Murazawa +4

    СтатьяHER2/EGFR in Cancer ResearchEuropean Journal of Cancer2012Цитирований: 0
    ABI

  5. 8-Oxoberberrubine

    Shakhnoza S. Azimova, Marat S. Yunusov

    ГлаваChronic Lymphocytic Leukemia Research2012Цитирований: 0
    ABI

  6. (−)-Tetrahydroberberrubine

    Shakhnoza S. Azimova, Marat S. Yunusov

    ГлаваCancer Treatment and Pharmacology2012Цитирований: 0
    ABI

  7. 101P Concentrations of soluble form of epidermal growth factor (oncoprotein SP 185) in systemic therapy

    L. Alimkhodjaeva, Н. А. Махмудова

    СтатьяHER2/EGFR in Cancer ResearchAnnals of Oncology2015Цитирований: 0
    ABI

  8. Morphological features of tumor in different treatment options for patients With Locally Advanced Breast Cancer

    Narzieyva D.F, Jonibekov J. J, Erkinova Sh.N

    СтатьяHER2/EGFR in Cancer ResearchMiddle European Scientific Bulletin2020Цитирований: 0
    ABI

  9. Effect of combined carriage of polymorphic markers ApoE (Ε2/Ε3/Ε4) and ApoA1 (G-75A) on the ApoB/ApoA-I ratio in CAD patients in the Uzbek population

    Р Алиева, Aleksandr B. Shek, А. А. Абдуллаев +4

    СтатьяAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis2023Цитирований: 0
    ABI

  10. APPROACHES TO THE TREATMENT OF METASTATIC BREAST CANCER

    Umida Ismailova Abdullayevna, Atahanova Nigora Ergashevna, Kurbankulov Uktam Muhammadovich +1

    СтатьяCancer Treatment and PharmacologyTexas Journal of Medical Science2024Цитирований: 0
    ABI

  11. Is early inclusion of neratinib with HER blockers possible in the treatment of stage 4 HER2 positive cancer?

    Zilola Avazovna Olimova

    СтатьяHER2/EGFR in Cancer ResearchJournal of Clinical Oncology2024Цитирований: 0
    ABI

  12. A clinical case of treatment of recurrent inoperable locally advanced breast cancer using conformal radiotherapy. Case report

    С. В. Медведев, M. Yu. Vlasova, Л. В. Болотина +10

    СтатьяBreast Cancer Treatment StudiesJournal of Modern Oncology2025Цитирований: 0
    ABI

  13. Design, synthesis, and evaluation of novel quinazoline derivatives as potent EGFR inhibitors: In silico and in vitro approaches

    Mohamed J. Saadh, Tamara Nazar Saeed, Karar H. Alfarttoosi +9

    СтатьяQuinazolinone synthesis and applicationsComputers in Biology and Medicine2025Цитирований: 0
    ABI

  14. INTEGRATED THERAPEUTIC STRATEGIES AND PERSONALIZED APPROACHES IN THE MANAGEMENT OF LUMINAL B HER2-NEGATIVE BREAST CANCER: A CLINICAL-STATISTICAL ANALYSIS

    Sevara Alimbayeva, Dilmurod Axadullayev, Akhmadjan Madaminov

    СтатьяBreast Cancer Treatment StudiesOpen MIND2026Цитирований: 0
    ABI

  15. INTEGRATED THERAPEUTIC STRATEGIES AND PERSONALIZED APPROACHES IN THE MANAGEMENT OF LUMINAL B HER2-NEGATIVE BREAST CANCER: A CLINICAL-STATISTICAL ANALYSIS

    Sevara Alimbayeva, Dilmurod Axadullayev, Akhmadjan Madaminov

    СтатьяBreast Cancer Treatment StudiesZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  16. 208 Correlation of HER2 FISH Status with Hormone Receptors, Ki-67, and Histologic Grade in Breast Carcinomas with HER2 IHC 2+ among Women in Uzbekistan

    Mirzabek Shodmonov Isokul Ugli, Madina Jakhongirova, Natalya Pak +3

    СтатьяHER2/EGFR in Cancer ResearchLaboratory Investigation2026Цитирований: 0
    ABI

  17. Molecular Mechanisms of Mammary Carcinogenesis: Current Understanding and Prospects for Targeted Therapy

    Ruzibakieva M.R., Jangavorov A.J., Ramziddinov J.J. +2

    СтатьяAdvanced Breast Cancer TherapiesInternational Journal of Medical Science and Public Health Research2026Цитирований: 0
    ABI